{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:08Z","timestamp":1790957588352,"version":"4.1.0"},"reference-count":93,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL141108"],"award-info":[{"award-number":["HL141108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health","award":["HL117724"],"award-info":[{"award-number":["HL117724"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular disease is the leading cause of morbidity and mortality in the Western and developing world, and the incidence of cardiovascular disease is increasing with the longer lifespan afforded by our modern lifestyle. Vascular diseases including coronary heart disease, high blood pressure, and stroke comprise the majority of cardiovascular diseases, and therefore represent a significant medical and socioeconomic burden on our society. It may not be surprising that these conditions overlap and potentiate each other when we consider the many cellular and molecular similarities between them. These intersecting points are manifested in clinical studies in which lipid lowering therapies reduce blood pressure, and anti-hypertensive medications reduce atherosclerotic plaque. At the molecular level, the vascular smooth muscle cell (VSMC) is the target, integrator, and effector cell of both atherogenic and the major effector protein of the hypertensive signal Angiotensin II (Ang II). Together, these signals can potentiate each other and prime the artery and exacerbate hypertension and atherosclerosis. Therefore, VSMCs are the fulcrum in progression of these diseases and, therefore, understanding the effects of atherogenic stimuli and Ang II on the VSMC is key to understanding and treating atherosclerosis and hypertension. In this review, we will examine studies in which hypertension and atherosclerosis intersect on the VSMC, and illustrate common pathways between these two diseases and vascular aging.<\/jats:p>","DOI":"10.3390\/ijms21124525","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T10:36:54Z","timestamp":1593081414000},"page":"4525","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9778-8652","authenticated-orcid":false,"given":"Amanda","family":"St. Paul","sequence":"first","affiliation":[{"name":"Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8687-6972","authenticated-orcid":false,"given":"Cali B.","family":"Corbett","sequence":"additional","affiliation":[{"name":"Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Okune","sequence":"additional","affiliation":[{"name":"Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-7577","authenticated-orcid":false,"given":"Michael V.","family":"Autieri","sequence":"additional","affiliation":[{"name":"Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tem.2013.10.002","article-title":"Proinflammation: The key to arterial aging","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1172\/JCI115261","article-title":"Minimally modified low density lipoprotein is biologically active in vivo in mice","volume":"87","author":"Liao","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.84.9.2995","article-title":"Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte\/macrophages during atherogenesis","volume":"84","author":"Quinn","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1990.tb42284.x","article-title":"Arterial metabolism of lipoproteins in relation to atherogenesis","volume":"598","author":"Steinberg","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction","volume":"3","author":"Tan","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","article-title":"Endothelial cell metabolism in normal and diseased vasculature","volume":"116","author":"Eelen","year":"2015","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular Smooth Muscle Cells in Atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","article-title":"Role of smooth muscle cells in the initiation and early progression of atherosclerosis","volume":"28","author":"Doran","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000155951.62152.2e","article-title":"Molecular determinants of vascular smooth muscle cell diversity","volume":"96","author":"Yoshida","year":"2005","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: A double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-0115(00)00178-6","article-title":"The multiple actions of angiotensin II in atherosclerosis","volume":"93","author":"Kagiyama","year":"2000","journal-title":"Regul. Pept."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00004872-200103001-00006","article-title":"Differential activation of extracellular signal-regulated protein kinase 1\/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats","volume":"19","author":"Touyz","year":"2001","journal-title":"J. Hypertens."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.RES.78.6.962","article-title":"Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype","volume":"78","author":"Lucchesi","year":"1996","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ndt\/16.suppl_1.27","article-title":"Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice","volume":"16","author":"Lorenzo","year":"2001","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.32.3.488","article-title":"Role of NADH\/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy","volume":"32","author":"Zafari","year":"1998","journal-title":"Hypertension"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","article-title":"p22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells","volume":"271","author":"Zafari","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: Role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"key":"ref_22","first-page":"H822","article-title":"Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor","volume":"250","author":"Rubanyi","year":"1986","journal-title":"Am. J. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/hy1201.100589","article-title":"Role of the renin-angiotensin system in vascular diseases: Expanding the field","volume":"38","author":"Lorenzo","year":"2001","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.ATV.18.9.1433","article-title":"Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits","volume":"18","author":"Yang","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_26","first-page":"2701","article-title":"Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression","volume":"272","author":"Nickenig","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/ATVBAHA.113.301777","article-title":"Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis","volume":"33","author":"Chen","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.CIR.102.16.1970","article-title":"Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: The potential role of transcription factor NF-kappaB","volume":"102","author":"Li","year":"2000","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2018.01.024","article-title":"Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction","volume":"271","author":"Wongsurawat","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijcard.2019.12.030","article-title":"Role of Serpina3 in vascular biology","volume":"304","author":"Sorokin","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbamcr.2016.11.019","article-title":"Identification of novel peptide motifs in the serpin maspin that affect vascular smooth muscle cell function","volume":"1864","author":"Jenkinson","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/hc0402.102619","article-title":"The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(98)00014-9","article-title":"Angiotensin, LDL peroxidation and atherosclerosis","volume":"63","author":"Keidar","year":"1998","journal-title":"Life Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.ATV.16.1.97","article-title":"Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation","volume":"16","author":"Keidar","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00249-017-1208-8","article-title":"Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein","volume":"47","author":"Sato","year":"2018","journal-title":"Eur. Biophys J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvn043","article-title":"Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: A new pro-atherogenic mechanism of hypertension","volume":"78","author":"Sendra","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/01.CIR.100.9.899","article-title":"Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein","volume":"100","author":"Morawietz","year":"1999","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.RES.84.9.1043","article-title":"Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation","volume":"84","author":"Li","year":"1999","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","article-title":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone","volume":"97","author":"Rajagopalan","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/157016106775203126","article-title":"Angiotensin II regulates vascular and endothelial dysfunction: Recent topics of Angiotensin II type-1 receptor signaling in the vasculature","volume":"4","author":"Nakashima","year":"2006","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Seto, S.W., Krishna, S.M., Yu, H., Liu, D., Khosla, S., and Golledge, J. (2013). Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-\/-) knockout mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058481"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cbf.1467","article-title":"Angiotensin II induces endothelial cell senescence via the activation of mitogen-activated protein kinases","volume":"26","author":"Shan","year":"2008","journal-title":"Cell Biochem. Funct."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/138920106776597667","article-title":"Current understanding of the mechanism and role of ROS in angiotensin II signal transduction","volume":"7","author":"Suzuki","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.RES.83.9.952","article-title":"Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells","volume":"83","author":"Chen","year":"1998","journal-title":"Circ. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000168210.10358.f4","article-title":"Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: A novel cross-talk in the pathogenesis of atherosclerosis","volume":"96","author":"Sahar","year":"2005","journal-title":"Circ. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zhang, F., Hu, Y., Xu, Q., and Ye, S. (2010). Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012323"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","article-title":"Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis","volume":"95","author":"Vaughan","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/ATVBAHA.112.249516","article-title":"Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-\/- mice","volume":"32","author":"Aono","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2009.01.025","article-title":"Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype","volume":"204","author":"Cheng","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.HYP.0000140269.55873.7b","article-title":"Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-\/- mice","volume":"44","author":"Mazzolai","year":"2004","journal-title":"Hypertension"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.ATV.19.11.2762","article-title":"Hypertension and endothelial dysfunction in apolipoprotein E knockout mice","volume":"19","author":"Yang","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.103.3.448","article-title":"Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice","volume":"103","author":"Weiss","year":"2001","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.P040139","article-title":"Prevention of TGF\u03b2 induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-\/- mice","volume":"54","author":"Tang","year":"2013","journal-title":"J. Lipid. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1074\/jbc.M113.520981","article-title":"Oxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling","volume":"289","author":"Barbariga","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1038\/s41598-017-06202-2","article-title":"Monocyte adhesion to atherosclerotic matrix proteins is enhanced by Asn-Gly-Arg deamidation","volume":"7","author":"Dutta","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/BJ20131471","article-title":"Oxidation modifies the structure and function of the extracellular matrix generated by human coronary artery endothelial cells","volume":"459","author":"Chuang","year":"2014","journal-title":"Biochem. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1006\/bbrc.1997.6844","article-title":"The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice","volume":"236","author":"Keidar","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0021-9150(94)90037-X","article-title":"Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids","volume":"108","author":"Kowala","year":"1994","journal-title":"Atherosclerosis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2004.08.023","article-title":"Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation","volume":"178","author":"Tham","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lee, S.G., Lee, S.J., Thuy, N.V.P., Kim, J.S., Lee, J.J., Lee, O.H., Kim, C.K., Oh, J., Park, S., and Kim, S.H. (2019). Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0215604"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1291\/hypres.31.1631","article-title":"The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis","volume":"31","author":"Eto","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","article-title":"Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice","volume":"110","author":"Wassmann","year":"2004","journal-title":"Circulation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIRCULATIONAHA.104.525550","article-title":"Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice","volume":"112","author":"Iwai","year":"2005","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2007.11.006","article-title":"Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression","volume":"199","author":"Hu","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic Effects of Statins on the Cardiovascular System","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/MCB.00989-10","article-title":"Therapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2","volume":"31","author":"Cho","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00005344-200004000-00006","article-title":"Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia","volume":"35","author":"Borghi","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0002-9149(99)00132-0","article-title":"Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)","volume":"83","author":"Mansur","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0975-3583.78596","article-title":"Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice","volume":"2","author":"Morgado","year":"2011","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"ref_73","first-page":"221","article-title":"Effect of rosuvastatin on systemic blood pressure in patients with hypercholesterolemia","volume":"17","author":"Seki","year":"2012","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00004872-200502000-00027","article-title":"Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus","volume":"23","author":"Rosei","year":"2005","journal-title":"J. Hypertens."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archinte.168.7.721","article-title":"Reduction in blood pressure with statins: Results from the UCSD Statin Study, a randomized trial","volume":"168","author":"Golomb","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s12325-019-01002-8","article-title":"Treatment of Hypertensive and Hypercholesterolaemic Patients with the Triple Fixed Combination of Atorvastatin, Perindopril and Amlodipine: The Results of the CORAL Study","volume":"36","author":"Simon","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1752-8062.2011.00378.x","article-title":"Nitric oxide-mediated endothlium-dependent vasodilation is impaired with borderline high-LDL cholesterol","volume":"5","author":"Diehl","year":"2012","journal-title":"Clin. Transl. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1159\/000362548","article-title":"Proinflammation of aging central arteries: A mini-review","volume":"60","author":"Wang","year":"2014","journal-title":"Gerontology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/01.ATV.20.6.1493","article-title":"Peripheral vascular endothelial dysfunction and apoptosis in old monkeys","volume":"20","author":"Asai","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cardiores.2004.12.027","article-title":"Endothelial aging","volume":"66","author":"Brandes","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCRESAHA.107.158626","article-title":"Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways","volume":"102","author":"Herbert","year":"2008","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/STROKEAHA.113.002649","article-title":"Longitudinal effects of a decade of aging on carotid artery stiffness: The multiethnic study of atherosclerosis","volume":"45","author":"Gepner","year":"2014","journal-title":"Stroke"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0002-9440(10)61229-1","article-title":"Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats","volume":"167","author":"Wang","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/HYPERTENSIONAHA.116.08041","article-title":"Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes","volume":"69","author":"Bruno","year":"2017","journal-title":"Hypertension"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","article-title":"Disruption of the Ang II type 1 receptor promotes longevity in mice","volume":"119","author":"Benigni","year":"2009","journal-title":"J. Clin. Invest."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jash.2012.01.006","article-title":"Angiotensin II type 2 receptor-interacting protein prevents vascular senescence","volume":"6","author":"Min","year":"2012","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellbi.2007.09.003","article-title":"Apoptosis is involved in the senescence of endothelial cells induced by angiotensin II","volume":"32","author":"Shan","year":"2008","journal-title":"Cell Biol. Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9149(01)01539-9","article-title":"Angiotensin II and atherosclerosis","volume":"87","author":"Weiss","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.119.315644","article-title":"Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis","volume":"126","author":"Tyrrell","year":"2020","journal-title":"Circ. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/ATVBAHA.111.236349","article-title":"Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells","volume":"32","author":"Song","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.RES.0000233315.38086.bc","article-title":"Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress","volume":"99","author":"Matthews","year":"2006","journal-title":"Circ. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4525\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:42:54Z","timestamp":1760175774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":93,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["ijms21124525"],"URL":"https:\/\/doi.org\/10.3390\/ijms21124525","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}